Connect Sign In
ARUP Laboratories has successfully completed the second surveillance assessment of its College of American Pathologists (CAP) International Organization for Standardization (ISO) 15189 accreditation.
ARUP Consult released new and updated resources on genetic cardiovascular disease, the effects of common anticoagulants on coagulation testing, laboratory testing for primary sclerosing cholangitis.
Deep Bio, a leading company in artificial intelligence (AI) cancer diagnostics, announced it obtained an approval from the University of IRB for a real-world implementation study.
Managing the challenge of a global healthcare crisis such as the COVID-19 pandemic requires collaboration, clear and abundant communication, and planning to allow a healthcare system to adapt.
About 200 research park and innovation district leaders from around the globe visited ARUP to hear how Research Park’s largest tenant has become a model for startups born in research institutions.
ARUP Consult® added new resources in September that provide expert guidance on preoperative testing for ovarian cancer biomarkers and testing strategies for malaria.
SALT LAKE CITY—The University of Utah Department of Pathology and ARUP Laboratories today announced the creation of the Harry R.
Harry R. Hill, MD, has been the force behind many firsts at ARUP Laboratories and the University of Utah.
AirMed and ARUP Blood Services commemorate a yearlong partnership in which ARUP has provided blood for AirMed to transfuse patients in flight.
Although vaccines have not brought the pandemic to its end, they have proven to be a potent tool in blocking the spread of the virus. But many wonder whether antibodies are doing their job.
Andrew Fletcher, MD, medical director of Consultative Services at ARUP Laboratories, and ARUP’s Consultative Services team, led by Sandy Richman, are honored with 2021 Choosing Wisely Champion Awards.
ARUP Laboratories has reconstructed an additional lab dedicated solely to high-throughput COVID-19 molecular diagnostic testing to meet renewed demand for testing.
